Acumen Pharmaceuticals (ABOS) Earnings Date & Reports
A.I. Advisor
published Earnings
ABOS is expected to report earnings to -34 cents per share on November 11
Q3'24
Est.
$-0.34
Q2'24
Missed
by $0.07
Q1'24
Beat
by $0.01
Q4'23
Missed
by $0.11
Q3'23
Beat
by $0.02
The last earnings report on August 13 showed earnings per share of -34 cents, missing the estimate of -27 cents. With 135.15K shares outstanding, the current market capitalization sits at 149.00M.